(Q37016245)

17 August 2017

1 reference

title

The immune response in Taenia solium cysticercosis: protection and injury (English)

1 reference

17 August 2017

0 references

0 references

Sciutto E

1

1 reference

17 August 2017

Chavarria A

2

1 reference

17 August 2017

Fragoso G

3

1 reference

17 August 2017

Fleury A

4

1 reference

17 August 2017

Larralde C

5

1 reference

17 August 2017

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

29

1 reference

17 August 2017

12

1 reference

17 August 2017

621-636

1 reference

Taenia tapeworms: their biology, evolution and socioeconomic significance

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Dogs as alternative intermediate hosts of Taenia solium in Papua (Irian Jaya), Indonesia confirmed by highly specific ELISA and immunoblot using native and recombinant antigens and mitochondrial DNA analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Taenia solium: the complex interactions, of biological, social, geographical and commercial factors, involved in the transmission dynamics of pig cysticercosis in highly endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Infections in Hispanic immigrants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Sequence variation in the cytochrome oxidase I, internal transcribed spacer 1, and Ts14 diagnostic antigen sequences of Taenia solium isolates from South and Central America, India, and Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Population genetic structure of Taenia solium from Madagascar and Mexico: implications for clinical profile diversity and immunological technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Detection of genetic variation in Taenia solium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Detection of serum antibodies in human Hymenolepis infection by enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

The seroprevalence of Taenia solium cysticercosis among epileptic patients in León, Nicaragua, as evaluated by ELISA and western blotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Cellular immune response of patients with neurocysticercosis (inflammatory and non-inflammatory phases).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Comparison of two assays (EIA and EITB) and two samples (saliva and serum) for the diagnosis of neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

In situ detection of antigenic glycoproteins in Taenia solium metacestodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Evaluation of an antigen from Taenia crassiceps cysticercus for the serodiagnosis of neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Serological diagnosis of neurocysticercosis: evaluation of ELISA tests using cyst fluid and other components of Taenia solium cysticerci as antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Taenia solium: identification of specific antibody binding regions of metacestode 10-kDa protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Cysticercosis: towards the design of a diagnostic kit based on synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Multiple genotypes of Taenia solium--ramifications for diagnosis, treatment and control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Serodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Immunological evaluation of a 26-kDa antigen from Taenia solium larvae for specific immunodiagnosis of human neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Immunochemical detection of antigens of larval Taenia solium and anti-larval antibodies in the cerebrospinal fluid of patients with neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Neurocysticercosis: relationship between the developmental stage of metacestode present and the titre of specific IgG in the cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

A seroepidemiological study of human cysticercosis in West Cameroon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Inhibitory role of antibodies in the development of Taenia solium and Taenia crassiceps toward reproductive and pathogenic stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

The role of N-linked carbohydrates in the antigenicity of Taenia solium metacestode glycoproteins of 12, 16 and 18 kD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Host--parasite relationship in cysticercosis: immunologic study in different compartments of the host.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Taenia solium: characterization of a small heat shock protein (Tsol-sHSP35.6) and its possible relevance to the diagnosis and pathogenesis of neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Human cerebral cysticercosis: immunolocalization of a sodium-dependent glucose cotransporter (SGLT) in larval and adult tapeworms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Structure and antigenicity of the major glycolipid from Taenia solium cysticerci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Antigenic proteins associated with calcareous corpuscules of taenia solium: partial characterization of a calcium-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Taenia solium cDNA sequence encoding a putative immunodiagnostic antigen for human cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Evaluation of purified Taenia solium glycoproteins and recombinant antigens in the serologic detection of human and swine cysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Paramyosin is the Schistosoma mansoni (Trematoda) homologue of antigen B from Taenia solium (Cestoda).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Cloning and sequencing of the gene encoding the principal 18-kDa secreted antigen of activated oncospheres of Taenia saginata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Treatment of neurocysticercosis: current status and future research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

The human nervous tissue in proximity to granulomatous lesions induced by Taenia solium metacestodes displays an active response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Comparison of cellular responses in single- and multiple-lesion neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

TH2 profile in asymptomatic Taenia solium human neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

See no evil, hear no evil, do no evil: the lessons of immune privilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

The expression and function of chemokines involved in CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Neuron-specific enolase in patients with neurocysticercosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Th1 and Th2 indices of the immune response in pigs vaccinated against Taenia solium cysticercosis suggest various host immune strategies against the parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Inflammatory responses in the intestinal mucosa of gerbils and hamsters experimentally infected with the adult stage of Taenia solium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Neuronal damage in brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Active secretion of S100B from astrocytes during metabolic stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Interleukin-10 therapy--review of a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Physiology of psychoneuroimmunology: a personal view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Neurocysticercosis among patients with cerebral gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Increased translocation frequency of chromosomes 7, 11 and 14 in lymphocytes from patients with neurocysticercosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Malignant transformation of high-grade astrocytoma associated with neurocysticercosis in a patient with Turcot syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Is dementia reversible in patients with neurocysticercosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Is neurocysticercosis a risk factor in coexistent intracranial disease? An MRI based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Immunoblot analysis of a 10 kDa antigen in cyst fluid ofTaenia soliummetacestodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

Characterization of GP39-42 and GP24 antigens from Taenia solium cysticerci and of their antigenic GP10 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2007.00967.X

10.1111/J.1365-3024.2007.00967.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference